Literature DB >> 26196262

Hepatitis C in children in times of change.

Robert D Baker1, Susan S Baker.   

Abstract

PURPOSE OF REVIEW: The global prevalence of hepatitis C infection is increasing. Here, hepatitis C infection in children is reviewed with the assumption that the new effective treatment will be available for treating children. RECENT
FINDINGS: Recently, effective treatment for hepatitis C infection has become available for adults. Understanding of vertical transmission, how frequently it occurs, which maternal and fetal factors can influence risks is critical in creating these new strategies. The natural history of vertically acquired disease, especially the chance of spontaneous clearance as well as the incidents of rapid progression, needs to be considered in deciding when or if to treat a child. The advantages and drawbacks to delayed treatment (pathophysiologic, psychological, societal, financial) should be considered with respect to the individual child and in a broader context.
SUMMARY: Although hepatitis C virus infection is not benign, it is usually very slowly progressive and is not easily transmitted through casual contact. With the expectation that effective treatment will soon be available to children, deferring treatment combined with cautious surveillance will optimize hepatitis C virus treatment for children.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26196262     DOI: 10.1097/MOP.0000000000000259

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  3 in total

Review 1.  The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.

Authors:  Christine Hong Ting Yang; Eric R Yoo; Aijaz Ahmed
Journal:  J Clin Transl Hepatol       Date:  2017-02-07

Review 2.  New prospects for the treatment and prevention of hepatitis C in children.

Authors:  Samantha Ohmer; Jonathan Honegger
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

Review 3.  Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C.

Authors:  Christine Hong Ting Yang; Aparna Goel; Aijaz Ahmed
Journal:  Adolesc Health Med Ther       Date:  2018-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.